Matinas生物制药（MTNB.US）股东结构 - 机构持仓、大股东与内部人士｜长桥证券

股东类型

公众及其他75.31%
个人与内部人士11.95%
私营企业10.16%
机构投资者2.58%

主要股东

主要股东最新
股东
Hezbay Holdings Llc	8.89%	130.65 万	4.93%	+105.26 万	2026/07/13
Adam SternFormer Director	8.16%	119.89 万	5.38%	+102.08 万	2026/07/10
David Lazar	3.71%	54.50 万	4.80%	+0	2025/08/15
111 Equity Group LLC	1.25%	18.36 万	1.62%	+0	2025/02/13
Renaissance Technologies LLC	0.48%	7.10 万	0.04%	+4.25 万	2026/06/30
Vanguard Capital Management, LLC	0.39%	5.74 万	0.52%	-961.00	2026/06/30
BlackRock, Inc.	0.34%	5.03 万	0.43%	+612.00	2026/06/30
Geode Capital Management, LLC	0.33%	4.91 万	0.68%	-1.60 万	2026/06/30
Holos Integrated Wealth, LLC	0.22%	3.25 万	0.29%	+0	2026/06/30
AKS Family Foundation	0.18%	2.65 万	0.23%	+0	2026/07/10
Stern Aegis Ventures, Llc Defined Benefit Plan	0.15%	2.14 万	0.19%	+0	2025/02/13
Susquehanna International Group, LLP	0.11%	1.61 万	0.11%	+1,765.00	2026/06/30
Citadel Advisors LLC	0.11%	1.55 万	0.70%	-3.62 万	2026/06/30
State Street Investment Management	0.10%	1.53 万	0.13%	+0	2026/06/30
Sargent Investment Group, LLC	0.09%	1.27 万	0.11%	+0	2026/06/30
Jerome JabbourCo-Founder, Chairman, CEO, President & Interim CFO	0.06%	9,207.00	0.08%	+0	2025/05/09
Pavilion Capital Partners LLC	0.04%	6,000.00	0.05%	+0	2026/07/10
Tower Research Capital Europe Limited	0.02%	2,853.00	0.03%	+0	2026/06/30
Keith KucinskiFormer Chief Financial Officer	0.01%	1,890.00	0.02%	+0	2025/05/09
Robert Eide	0.01%	1,500.00	0.01%	+0	2025/04/08